P Kestelyn1. 1. Department of Ophthalmology, University Hospital, Gent, Belgium.
Abstract
AIM: To analyze the prevalence of cytomegalovirus (CMV) retinitis in African AIDS patients. METHOD: A Medline survey was carried out to identify reports on the ocular manifestations of HIV infection in African patients. Relevant information on CMV retinitis was identified and analyzed. RESULTS: The reported prevalence of CMV retinitis in African AIDS patients varies from 0 to 8.5%. CONCLUSION: The low prevalence of CMV retinitis in Africa compared to Europe and the United States suggests that most African patients either die from other diseases before they enter the stage of severe immune depression associated with CMV disease or their survival at this stage is very short. This also explains why bilateral and hence blinding CMV retinitis is rare among African AIDS patients.
AIM: To analyze the prevalence of cytomegalovirus (CMV) retinitis in African AIDSpatients. METHOD: A Medline survey was carried out to identify reports on the ocular manifestations of HIV infection in African patients. Relevant information on CMV retinitis was identified and analyzed. RESULTS: The reported prevalence of CMV retinitis in African AIDSpatients varies from 0 to 8.5%. CONCLUSION: The low prevalence of CMV retinitis in Africa compared to Europe and the United States suggests that most African patients either die from other diseases before they enter the stage of severe immune depression associated with CMV disease or their survival at this stage is very short. This also explains why bilateral and hence blinding CMV retinitis is rare among African AIDSpatients.
Authors: Somsanguan Ausayakhun; Alison H Skalet; Choeng Jirawison; Sakarin Ausayakhun; Jeremy D Keenan; Claire Khouri; Khang Nguyen; Partho S Kalyani; David Heiden; Gary N Holland; Todd P Margolis Journal: Am J Ophthalmol Date: 2011-09-08 Impact factor: 5.258
Authors: N A V Beare; J G Kublin; D K Lewis; M J Schijffelen; R P H Peters; G Joaki; J Kumwenda; E E Zijlstra Journal: Br J Ophthalmol Date: 2002-10 Impact factor: 4.638
Authors: Mark A Jacobson; Qi Xuan Tan; Valerie Girling; C Poon; Mark Van Natta; Douglas A Jabs; Margaret Inokuma; Holden T Maecker; Barry Bredt; Elizabeth Sinclair Journal: Clin Infect Dis Date: 2008-02-01 Impact factor: 9.079
Authors: Nav Beare; J G Kublin; D K Lewis; M J Schijffelen; Rph Peters; G Joaki; K Kumwenda; E E Zijlstra Journal: Malawi Med J Date: 2003 Impact factor: 0.875